Lulla Opatowski's winning project is titled 'Anti-Resistance - Towards a global predictive framework for antimicrobial resistance: building a UK–France network'. It aligns with the priorities of the Franco-British Science and Technology Joint Committee (COMIXTE) regarding artificial intelligence and health.
Opatowski's research, head of the 'Infectious diseases, interactions and escape from anti-infectives' team at the Center for Research in Epidemiology and Population Health (CESP – UVSQ/Inserm/Univ. Paris-Saclay), focuses on bacterial resistance to antimicrobials, including antibiotics and vaccines. She also studies interactions between the host, pathogen, and other pathogens, combining mathematical modeling, statistical inference, and data collection.
The Sophie Germain project call, now in its third edition, saw a growing interest with 105 applications this year, compared to 48 in 2025 and 29 in 2024. Ten projects were selected from 31 proposals that received an A+ rating, representing a selection rate of approximately 10%.
The 'Anti-Resistance' project is a collaboration with the London School of Hygiene & Tropical Medicine.
